GLP-1 Telehealth: What PMHNPs Need to Know in Florida

You’re already seeing it in your practice: patients on Zyprexa who’ve gained 40 pounds asking what they can do. Patients on mood stabilizers struggling with metabolic syndrome. And now, with GLP-1 medications everywhere in the news, you’re fielding questions about Ozempic and Wegovy during psychiatric visits.

Here’s the reality: weight management is becoming part of psychiatric care, whether we planned for it or not. By 2025, an estimated 6% of Americans (around 20 million people) were actively taking GLP-1 drugs for weight loss or diabetes — a market that barely existed five years ago. And nearly half of psychiatrists surveyed are already prescribing or recommending these medications.

The question isn’t whether psychiatrists should engage with GLP-1 prescribing. It’s how to do it sustainably — building a scalable weight-loss practice that doesn’t add another 20 hours to your week or leave you answering patient messages at midnight.

This guide walks through the practical reality: how to attract GLP-1 patients, what telehealth compliance actually requires in major states, and most importantly, how to structure workflows that let you scale without burning out.

Why Psychiatrists Are Uniquely Positioned for GLP-1 Care

The Patient Overlap You Already Have

If you prescribe psychiatric medications, you’re already managing weight gain as a side effect. Antipsychotics, mood stabilizers, and certain antidepressants cause significant metabolic changes — weight gain that affects medication adherence, self-esteem, and physical health outcomes.

GLP-1 medications offer a medical solution to medication-induced weight gain. Instead of switching a patient off an effective psychiatric drug because of weight concerns, you can now address both the mental health condition and the metabolic consequences. This integrated approach is what patients actually want: one provider who understands the whole picture.

Beyond medication side effects, psychiatric patients frequently struggle with binge eating disorder, emotional eating, and obesity-related depression. The behavioral component of weight loss — motivation, habit change, managing setbacks — is territory psychiatrists navigate daily. You’re not just prescribing a medication; you’re providing the psychological support that makes long-term weight management work.

The Market Opportunity Is Massive

Roughly 75% of Americans are overweight or obese. GLP-1 usage has increased 600% over six years for weight loss alone. Tens of thousands of new patients start these medications every week.

The supply of obesity medicine specialists can’t keep up. Patients are seeking care from any qualified provider — and psychiatrists with prescriptive authority (MD, DO, or PMHNP in many states) can fill that gap. This isn’t a niche service; it’s addressing a chronic disease that affects the majority of your potential patient population.

The financial opportunity is real, but it has to be structured correctly. Many telehealth GLP-1 practices favor cash-pay models because insurance coverage for obesity medications remains limited. As of 2024, only 13 state Medicaid programs covered GLP-1s for weight loss. Most private insurers exclude them or require extensive prior authorizations. This means patients expect to pay out-of-pocket — creating a market for subscription-based or fee-per-visit models that generate direct revenue.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

How to Get GLP-1 Patients as a Psychiatrist

Start With Your Existing Caseload

The easiest first step: identify patients in your current practice who meet criteria for GLP-1 therapy (BMI ≥30, or BMI ≥27 with weight-related comorbidities like hypertension or prediabetes).

During routine medication reviews, introduce the option: ‘I know you’ve mentioned frustration about the weight gain from your medication. There are now effective prescription treatments for weight loss that I can prescribe. Would you want to discuss that?’

This approach requires zero marketing spend. You’re addressing an existing patient concern and expanding the care you provide. Many patients will say yes immediately — they’ve been waiting for someone to help with weight, not just psychiatric symptoms.

Document this as part of comprehensive care. You’re not adding a separate ‘weight-loss practice’; you’re managing the full metabolic and mental health picture for patients you already know.

External Patient Acquisition: The Smart Way

If you want to scale beyond your current panel, you need patient acquisition channels. Here’s where most providers waste money: jumping into Google Ads or SEO without understanding the real economics.

The DIY Marketing Reality:

• SEO takes 6-12 months of consistent investment before generating meaningful traffic. You’re competing with established weight-loss clinics, telehealth startups, and every other provider chasing the same keywords. Realistically, it costs thousands in content creation, site optimization, and patience before you see ROI.
• Google Ads for ‘GLP-1 prescriber’ or ‘weight loss doctor’ run $15-40+ per click. Most clicks don’t convert to booked patients. Factor in agency fees, failed campaigns, and the time spent managing ads, and your cost per acquired patient is easily $200-400+.
• Directory Listings (Psychology Today, Zocdoc) charge monthly fees and per-booking fees. You’re listed alongside hundreds of other providers. Zocdoc’s booking fees range from $35-100+, and you’re still paying a monthly subscription on top of that.

When you add up the real costs — staff time to handle leads, no-show rates from cold inquiries, months of testing and optimization — acquiring a qualified psychiatric patient through DIY channels typically costs $200-500+. And that’s if you have the expertise and budget to execute well.

The Platform Alternative:

Instead of gambling on marketing channels, consider platforms that deliver pre-qualified patients on a pay-per-appointment model.

Platforms like Klarity Health use a structure similar to Zocdoc: you pay a standard listing fee per new patient lead, but there are no upfront marketing costs or monthly subscriptions. The value proposition:

• No wasted ad spend on clicks that don’t convert
• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate EMR or video platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you actually see patients

Frame this economically: instead of spending $3,000-5,000/month on uncertain marketing experiments, you pay only when a qualified patient books with you. That’s guaranteed ROI versus gambling on channels you might not have time to manage.

DIY marketing can be cost-effective long-term if you have the budget, expertise, and patience. But for most providers — especially those starting out or scaling quickly — removing the patient acquisition risk entirely lets you focus on clinical care instead of becoming a marketing expert.

Referral Networks and Niche Positioning

Build relationships with primary care physicians, endocrinologists, therapists, and dietitians in your area. Let them know you offer GLP-1 prescribing with a psychiatric focus — emphasizing that you manage the mental health side of weight loss (motivation, emotional eating, mood effects of rapid weight change).

Many PCPs are overwhelmed with GLP-1 requests but lack time for the behavioral counseling piece. Position yourself as the specialist who handles the psychological complexity they can’t address in 15-minute visits.

Market your unique combination: ‘Psychiatrist offering medical weight management with integrated mental health support.’ This differentiates you from generic telehealth weight-loss clinics and attracts patients who value comprehensive care.

GLP-1 Telehealth Compliance: What You Actually Need to Know

Licensure Rules by State

You must be licensed in the state where the patient is located. GLP-1 medications are not controlled substances, so the Ryan Haight Act’s in-person exam requirement doesn’t apply — you can legally prescribe semaglutide via telehealth without ever seeing the patient face-to-face.

However, state-specific rules for telehealth and scope of practice still apply:

For Psychiatrists (MD/DO):

• You have full prescriptive authority for GLP-1s in any state where you hold a license
• States in the Interstate Medical Licensure Compact (IMLC) — Texas, Pennsylvania, Illinois, Florida — offer expedited licensing across member states
• California and New York are NOT in the IMLC, requiring full state licensure
• Florida offers a special out-of-state telehealth provider registration that allows physicians licensed elsewhere to practice telemedicine in Florida without full FL licensure (though it restricts controlled substance prescribing, GLP-1s are not affected)

For Psychiatric NPs (PMHNPs):

Scope of practice varies significantly:

Telehealth Standard of Care

Each state requires that telehealth care meet the same standard as in-person care. For GLP-1 prescribing, this means:

Initial Evaluation:

• Comprehensive history (weight history, current medications, medical conditions, mental health status)
• Assessment of contraindications (history of medullary thyroid cancer, pancreatitis, multiple endocrine neoplasia)
• Baseline labs: A1c, fasting glucose, liver enzymes, TSH (if indicated)
• BMI calculation and documentation of obesity diagnosis
• Discussion of lifestyle modifications, realistic expectations, potential side effects
• Informed consent for off-label use (if prescribing Ozempic for obesity rather than Wegovy)

State-Specific Telehealth Requirements:

• California: Requires documented patient consent for telehealth (verbal or written)
• Texas: Allows audio-visual telehealth to establish patient relationship; audio-only permitted for mental health but requires video for initial weight-loss evaluation
• Florida: No mandatory in-person visit; adequate telehealth evaluation sufficient
• New York: No special restrictions; standard of care via any appropriate modality
• Pennsylvania: Board expects equivalent evaluation to in-person; video consult acceptable
• Illinois: Comprehensive telehealth parity law; no in-person requirement for non-controlled substances

What About Compounded Semaglutide?

Many telehealth weight-loss practices use compounded semaglutide to offer lower-cost options when brand-name medications are unaffordable or in shortage. Compounding is legal, but the FDA has issued warnings about quality control from unregulated suppliers.

Best practices:

• Partner only with FDA-registered 503B compounding facilities (outsourcing facilities subject to FDA inspection)
• Verify the pharmacy’s state licenses and track record
• Educate patients about the difference between FDA-approved medications and compounded versions
• Document informed consent for compounded medications

If you’re uncertain about compounding pharmacy quality, stick to FDA-approved brands (Wegovy, Saxenda, Zepbound) to minimize liability risk.

Malpractice Coverage

Notify your malpractice carrier that you’re prescribing weight-loss medications. This typically falls within general medical practice for physicians, but some NP policies might have specialty restrictions. Confirm coverage to avoid gaps.

Scaling Without Burnout: Practical Workflow Design

The Initial Intensive Phase

GLP-1 patients require front-loaded work: comprehensive intake, lab review, medication education, goal-setting. If you try to fit this into standard 30-minute psychiatric slots alongside your existing caseload, you’ll burn out in weeks.

Structured Intake Process:

Create a dedicated 60-minute initial GLP-1 consult template:

• Pre-visit: Patient completes digital intake forms covering weight history, diet, exercise, medical conditions, psychiatric history, current medications
• Labs ordered before visit (or at visit for follow-up review)
• Visit agenda:
• Review medical/psych history and labs (10 min)
• Obesity diagnosis documentation and BMI calculation (5 min)
• Medication education: mechanism, dosing schedule, injection technique, side effects (15 min)
• Behavioral counseling: nutrition basics, exercise goals, mental health and weight connection (15 min)
• Informed consent and prescription (10 min)
• Schedule follow-ups (5 min)

Use template documentation for common elements. Create dot phrases or smartphrases in your EMR:

• ‘.glp1intake’ auto-populates obesity diagnosis with BMI, contraindication screening, informed consent language
• ‘.glp1f/u’ auto-populates follow-up template with weight trend, side effects checklist, dose titration protocol

This cuts documentation time from 20 minutes to 5 minutes per visit.

Follow-Up Cadence: Monthly Early, Quarterly Later

During months 1-6, patients need monthly follow-ups for dose titration and side effect management. These can be shorter (15-20 minutes) because you’re not doing full intake.

Efficient Follow-Up Structure:

• Patient reports current weight via portal message or app before visit (staff enters in chart)
• Review weight trend graph (auto-generated in EMR or tracking app)
• Brief check-in: side effects, adherence, barriers, mental health
• Dose adjustment if needed (standard titration protocol: increase every 4 weeks if tolerating and not at goal)
• Reinforce behavioral strategies
• Rx refill and schedule next visit

After 6 months, stable patients can move to every 2-3 month follow-ups. Some practices use asynchronous check-ins between visits: patients submit weight and brief update via portal, you review and respond in batch (compensate yourself for this time with chronic care management codes or build it into subscription fee).

Team-Based Care: Delegate Everything You Can

You don’t need to handle every aspect of weight management personally.

Delegation Strategy:

For a solo practice, consider contracting with a virtual health coach or dietitian for monthly group sessions with your GLP-1 patients. A 30-minute Zoom call with 10 patients costs you one hour of contracted time but provides ongoing support that reduces individual counseling burden.

If you’re in a group practice or have NP supervision authority, create a collaborative care model: you do initial evaluations for complex cases (psychiatric medication interactions, eating disorders), while a PMHNP or NP handles routine follow-ups under your oversight. You review charts weekly and are available for consultation, but you’re not seeing every patient every month.

Technology: Automate and Monitor Remotely

Leverage telehealth platforms with integrated features:

Essential Tech Stack:

• Telehealth EMR with video visits, e-prescribing, patient portal messaging (Doxy.me, SimplePractice, Klarity’s integrated platform)
• Automated appointment reminders and online self-scheduling (reduces phone tag)
• Patient tracking apps: Have patients use free apps (MyFitnessPal, Lose It) or invest in a chronic care platform that syncs weight data to your EMR
• Template libraries: Pre-built intake forms, consent forms, patient education handouts
• Batch messaging: Set aside 30 minutes daily to respond to portal messages rather than interrupting your day

Remote Monitoring:Some practices issue connected scales or use RPM (remote patient monitoring) platforms. Patients weigh in weekly; data syncs to your dashboard. You quickly review trends and only intervene if someone plateaus or reports problems. RPM can also be billable under certain circumstances (Medicare RPM codes), adding revenue while reducing visit frequency.

AI and Chatbots:For common questions (‘Is nausea normal?’ ‘When do I increase my dose?’), automated chatbots or FAQ libraries can provide instant answers. This doesn’t replace you, but it reduces repetitive inquiries.

Retention Strategies: Keep Patients Engaged Without Extra Work

Weight loss is a long-term process. Patients who feel supported stay longer and get better results — but you can’t personally call every patient weekly to check in.

Scalable Support Structures:

• Monthly group visits: Host a 30-minute virtual ‘GLP-1 support group’ where patients share experiences, you answer common questions, and everyone benefits from peer support. Bill this as group counseling or include it in a monthly membership fee.
• Educational email series: Create a 6-month drip campaign of weekly emails with tips, recipes, motivation. Automate it. Patients feel continuously supported without requiring your time.
• Private online community: Facebook group or Slack channel where patients can connect. You or a health coach monitor and occasionally chime in, but patients support each other day-to-day.
• Milestone celebrations: Automated messages congratulating patients when they hit weight-loss milestones (based on EMR data triggers). Small touch that reinforces progress.

Preventing Burnout: Boundaries and Capacity Management

Even with efficient workflows, you can burn out if you don’t manage capacity.

Protect Your Time:

• Limit daily GLP-1 consults: If you’re also maintaining a psychiatric practice, cap weight-loss appointments to 4-6 per day. Block the rest of your schedule for psych patients or admin time.
• Set communication hours: Make it clear that portal messages are answered within 24-48 business hours, not immediately. Use auto-replies for after-hours messages.
• Batch prescription refills: Instead of handling refills as they trickle in, set a specific time twice weekly to process all refills at once.
• Take vacations: Build a coverage system (another prescriber who can handle urgent issues, or a protocol for patients to pause medication if you’re unavailable for a week). Don’t let guilt about patient continuity trap you.

Monitor Your Own Burnout Signals:

Watch for emotional exhaustion, cynicism about patients, declining satisfaction. If you notice these, it’s time to reassess:

• Are you taking on too many patients too fast?
• Are you doing tasks that could be delegated?
• Do you need to hire support staff or contract services?
• Should you pause new patient intake while you stabilize operations?

Research shows that schedule control and virtual practice flexibility reduce physician burnout. Telehealth gives you that flexibility — work from home, set your own hours — but only if you actively protect boundaries. Saying no to evening appointments or capping your panel size isn’t selfish; it’s sustainable practice.

The Financial Model: Cash-Pay vs Insurance

Cash-Pay Advantages:

• Simple operations: patient pays directly, no billing department needed
• Higher revenue per visit: charge $150-250 for initial consult, $75-150 for follow-ups
• Pair with medication subscriptions: some practices charge monthly membership ($99-199/month) that includes consults, medication coordination, and support resources

Cash-Pay Challenges:

• Limits access for lower-income patients
• Requires upfront marketing investment to attract cash-paying demographic
• Patients sensitive to medication costs (brand Wegovy is $1,300+/month without insurance; compounded semaglutide $200-400/month)

Insurance Model Advantages:

• Broader patient access
• Leverage existing insurance relationships if you’re already paneled
• Some states (CA, PA, IL) now have Medicaid coverage for GLP-1 obesity treatment, expanding patient pool

Insurance Model Challenges:

• Prior authorizations for medications (time-consuming, often denied)
• Lower reimbursement for visits (standard E/M codes)
• Complex billing for obesity counseling (G0447 Medicare code, not all insurers reimburse equivalently)

Hybrid Approach:Charge cash for initial consult (comprehensive evaluation not fully reimbursed by insurance), then bill insurance for follow-ups using appropriate E/M codes. Be transparent with patients about which services are self-pay vs billable.

Medication costs: If patients have insurance that covers GLP-1s for diabetes, help them get a diabetes diagnosis on file if clinically appropriate (many obese patients are prediabetic). If no coverage, guide them to patient assistance programs (Novo Nordisk, Eli Lilly offer savings cards) or compounding pharmacy options.

State-by-State Regulatory Summary for Priority Markets

California

• Licensing: Full CA medical license required (not in IMLC)
• NP Practice: Transitioning to independence via AB 890; until 2026, PMHNPs need physician supervision
• Telehealth: Requires patient consent; video visit acceptable to establish care
• Market Notes: Medi-Cal covers GLP-1s for obesity as of 2024; large, diverse patient population with high demand

Texas

• Licensing: TX license or IMLC expedited license
• NP Practice: Strict collaboration required; one physician can supervise up to 7 NPs/PAs
• Telehealth: Audio-visual consult required for weight-loss evaluation; no in-person mandate
• Market Notes: High obesity rate (~35%); underserved rural areas; strong demand for telehealth access

Florida

• Licensing: FL license or out-of-state telehealth registration for MDs
• NP Practice: PMHNPs need physician collaboration (autonomous status only for primary care NPs)
• Telehealth: No in-person requirement; adequate video eval sufficient
• Market Notes: Large market with retirement population; limited insurance coverage means mostly cash-pay patients

New York

• Licensing: Full NY license required (not in IMLC)
• NP Practice: Full practice authority after 3,600 hours; newer NPs need collaboration
• Telehealth: Standard of care via any appropriate modality; strong telehealth parity laws
• Market Notes: NYC highly competitive; upstate and rural areas underserved

Pennsylvania

• Licensing: PA license or IMLC expedited
• NP Practice: All NPs require physician collaborative agreement; no independent practice
• Telehealth: Video consult acceptable; no blanket in-person requirement
• Market Notes: PA Medicaid covers GLP-1s for obesity; mix of urban/rural demand

Illinois

• Licensing: IL license or IMLC expedited
• NP Practice: Full Practice Authority available after 4,000 hours + education
• Telehealth: Comprehensive parity law; no in-person requirement for non-controlled substances
• Market Notes: IL Medicaid covers GLP-1s; strong telehealth support; urban centers competitive but statewide demand high

FAQ: GLP-1 Practice Questions Psychiatrists Actually Ask

Q: Do I need special training or certification to prescribe GLP-1s?

A: No mandatory certification, but consider CME in obesity medicine. The American Board of Obesity Medicine offers courses and diplomate certification if you want formal credentials. At minimum, familiarize yourself with prescribing guidelines, contraindications, and dose titration protocols. Many platforms and compounding pharmacies provide free training webinars.

Q: Can I prescribe GLP-1s for patients who just want to lose 10-15 pounds for cosmetic reasons?

A: FDA approval is for BMI ≥30 or BMI ≥27 with comorbidities. Prescribing outside these criteria is off-label and harder to justify medically. Stick to patients who meet clinical criteria to avoid liability and ensure you’re treating obesity as a disease, not providing cosmetic enhancement.

Q: What if a patient develops suicidal thoughts on a GLP-1?

A: The FDA reviewed this concern in 2024-2025 and found no causal link, even removing suicide warnings from labels. However, as a psychiatrist, monitor mental health closely. If mood changes occur, assess whether they’re related to the medication, rapid weight loss stress, or underlying psychiatric condition. You’re uniquely qualified to manage this — it’s a competitive advantage.

Q: How do I handle patients who plateau or regain weight?

A: Weight plateaus are normal. Reassess diet and exercise adherence, consider dose increase if not at max, and provide psychological support for frustration. Some patients need adjunct therapies (adding a second agent, behavioral therapy referral). Others may need a medication break. This is where your psychiatric skills shine — addressing the emotional component of weight loss.

Q: What’s my liability exposure if something goes wrong?

A: Follow standard of care: proper patient selection, informed consent, appropriate monitoring, documentation. GLP-1s have a strong safety profile when prescribed correctly. Major risks (pancreatitis, thyroid tumors) are rare and mostly theoretical. Malpractice claims are unlikely if you practice within guidelines. Update your malpractice insurance and document thoroughly.

Q: Can I do this part-time while maintaining my psychiatric practice?

A: Absolutely. Many psychiatrists start with 5-10 GLP-1 patients and scale gradually. Block one afternoon per week for weight-loss consults. Test your workflows, refine your templates, and expand only when you’re comfortable. You don’t have to become a full-time obesity medicine specialist overnight.

Q: How much can I realistically earn from a GLP-1 practice?

A: Cash-pay model: $150-250 per initial consult, $75-150 per follow-up. If you see 20 new GLP-1 patients per month and maintain 50 ongoing patients with monthly follow-ups, that’s approximately $3,000-5,000 in initial consults plus $3,750-7,500 in follow-ups monthly — $6,750-12,500/month or $81,000-150,000/year for a part-time service line. Insurance reimbursement is lower but more predictable. Subscription models can generate recurring revenue: $99-199/month per patient × 50 patients = $4,950-9,950/month.

Ready to Scale Smartly?

The GLP-1 weight-loss market isn’t slowing down — patient demand is only increasing. Psychiatrists have a unique opportunity to meet that demand while leveraging skills you already have: managing chronic conditions, supporting behavior change, addressing the mental health dimensions of obesity.

But scaling a GLP-1 practice without burning out requires intentional design: efficient workflows, team-based delegation, technology that works for you (not against you), and clear boundaries that protect your time and energy.

If you’re looking for a patient acquisition model that removes the marketing gamble and delivers pre-qualified patients, consider platforms that handle the heavy lifting while you focus on clinical care. Klarity Health connects psychiatrists and PMHNPs with patients seeking both mental health treatment and weight management services — a natural fit for integrated care.

The economic model is straightforward: no upfront marketing costs, no monthly subscriptions, just a standard fee per new patient appointment. You control your schedule, set your availability, and get matched with patients who actually show up ready to start treatment.

Instead of spending months testing Google Ads or building SEO traction, you can start seeing GLP-1 patients next week — with the infrastructure, compliance support, and patient flow already in place.

Explore Klarity’s provider network and see if it’s the right fit for scaling your practice sustainably. Because the goal isn’t just more patients — it’s building a practice you can maintain long-term without sacrificing your own health in the process.

References

1. Axios. ‘Just how many Americans are taking GLP-1s now.’ May 27, 2025. Available at: https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing

2. ConfectioneryNews. ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry.’ October 20, 2025. Available at: https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry

3. Time. ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny.’ August 22, 2025. Available at: https://time.com/7311517/cost-weight-loss-drugs-skinny/

4. Axios. ‘America’s doctors need more obesity medicine training.’ May 28, 2024. Available at: https://www.axios.com/2024/05/28/us-doctors-obesity-health-care-training

5. Axios. ‘States slow to cover GLP-1s for weight loss.’ November 5, 2024. Available at: https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is